{
  "trial_id": "NCT00391157",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "willing and able to comply with protocol requirements",
      "label": "met",
      "evidence": "patient's opinion"
    },
    {
      "criterion": "given voluntary written informed consent",
      "label": "met",
      "evidence": "patient's understanding"
    },
    {
      "criterion": "age over 18 and under 65 years old",
      "label": "met",
      "evidence": "patient's age"
    },
    {
      "criterion": "recently diagnosed with symptomatic Multiple Myeloma",
      "label": "met",
      "evidence": "standard criteria"
    },
    {
      "criterion": "has measurable disease",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "ECOG performance status < 2",
      "label": "met",
      "evidence": "patient's condition"
    },
    {
      "criterion": "life-expectancy >3 months",
      "label": "met",
      "evidence": "patient's prognosis"
    },
    {
      "criterion": "laboratory values within 14 days before Baseline visit",
      "label": "unknown",
      "evidence": ""
    }
  ],
  "exclusion": [
    {
      "criterion": "previously received treatment with VELCADE",
      "label": "not_met",
      "evidence": "no mention of previous treatment"
    },
    {
      "criterion": "previously received treatment for Multiple Myeloma",
      "label": "met",
      "evidence": "patient's history"
    },
    {
      "criterion": "had major surgery within 4 weeks before enrollment",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "platelet count < 50x 109/L within 14 days before enrollment",
      "label": "not_met",
      "evidence": "patient's lab results"
    },
    {
      "criterion": "absolute neutrophil count < 1.0 x 109/L within 14 days before enrollment",
      "label": "not_met",
      "evidence": "patient's lab results"
    },
    {
      "criterion": "hypersensitivity to bortezomib, boron or mannitol",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "received other investigational drugs within 14 days before enrollment",
      "label": "not_met",
      "evidence": "no mention of previous treatment"
    },
    {
      "criterion": "known to be seropositive for the human immunodeficiency virus (HIV)",
      "label": "unknown",
      "evidence": ""
    }
  ],
  "notes": "Patient has multiple myeloma with recurrent disease and systemic amyloidosis. She is on hemodialysis for ESRD and has been treated with various medications, including melphalan, prednisone, VAD regimen, and thalidomide.",
  "_meta": {
    "topic_id": "17",
    "trial_id": "NCT00391157",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}